Series B funding round for CancerIQ raising $14M in March 2022
Series B funding round for CancerIQ raising $14M in March 2022
| Investor | Firm Type | Partner |
|---|
Amgen VenturesLEAD | Corporate Venture Capital | — |
Merck GroupLEAD | Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$19M
Top Valuation
-
CancerIQ raised $14M in a Series B round.
The round was announced on 03/01/22.
The round was led by Amgen Ventures, Joel Krikston.